Timothy Kelly
Hoofd Techniek/Wetenschap/O&O bij CARIBOU BIOSCIENCES, INC.
Oorsprong van het eerstegraads netwerk van Timothy Kelly
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
79
| Subsidiary | Pharmaceuticals: Major | 79 |
79
| Public Company | Pharmaceuticals: Major | 79 |
28
| Public Company | Pharmaceuticals: Major | 28 |
| Public Company | Biotechnology | 16 | |
13
| Extinct | Pharmaceuticals: Major | 13 |
| Public Company | Pharmaceuticals: Major | 4 | |
Oxford Biomedica Solutions LLC
 Oxford Biomedica Solutions LLC Industrial MachineryProducer Manufacturing Oxford Biomedica Solutions LLC is a development partner that offers a plug and play platform for partners to achieve high titer and high product quality vector. The platform has already been proven with six separate new product inds and ctas. The American company's approach to AAV manufacturing is through continuous innovation to ensure they are delivering the highest product quality and efficacy to patients. The CEO of the joint venture company is Timothy P. Kelly.
1
| Joint Venture | Industrial Machinery | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Timothy Kelly via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BAXTER INTERNATIONAL INC. | Medical Specialties | Director/Board Member Director/Board Member President | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Human Resources Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
| PEPSICO, INC. | Food: Specialty/Candy | Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | President Director/Board Member Public Communications Contact | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Sales & Marketing | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member Chief Executive Officer Public Communications Contact General Counsel | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Sales & Marketing | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| ALMIRALL, S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| BAXALTA INC | Biotechnology | Director/Board Member Director/Board Member | |
| Dartmouth College | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| RECKITT BENCKISER GROUP PLC | Household/Personal Care | Director/Board Member Corporate Secretary General Counsel | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Chairman Chairman | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Director/Board Member Chairman Chairman | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Arizona | College/University | Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Hospital/Nursing Management | Director/Board Member Corporate Officer/Principal | |
| University College London | College/University | Graduate Degree Corporate Officer/Principal | |
| European Round Table of Industrialists | Corporate Officer/Principal Corporate Officer/Principal | ||
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member President Director/Board Member | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Operating Officer Director of Finance/CFO | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
Zeneca Pharmaceuticals
 Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
Interpharma
 Interpharma Miscellaneous Commercial ServicesCommercial Services Interpharma operates as an association of research-based pharmaceutical companies in Switzerland. It provides information on the pharmaceuticals market, healthcare system, and biomedical research. The company is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Chairman Chief Executive Officer Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin | |
| EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Executive Officer | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Founder Public Communications Contact | |
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member | |
| CERVOMED INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 37 |
| Verenigd Koninkrijk | 5 |
| Duitsland | 3 |
| Zwitserland | 3 |
| België | 3 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 12 |
| Commercial Services | 6 |
| Health Services | 4 |
| Consumer Non-Durables | 3 |
Operationeel
| Director/Board Member | 566 |
| Corporate Officer/Principal | 234 |
| Independent Dir/Board Member | 216 |
| Chairman | 158 |
| Undergraduate Degree | 81 |
Sterkste connecties
| Insiders | |
|---|---|
| Steven Gillis | 58 |
| Thomas Leysen | 36 |
| Mark McDade | 35 |
| Mahendra Shah | 34 |
| Flemming Ørnskov | 34 |
| William Young | 32 |
| Michael Bonney | 32 |
| Robert Perez | 31 |
| Thomas Fulton Wilson McKillop | 28 |
| Hans-Peter Hasler | 28 |
| William Burns | 27 |
| Scott Braunstein | 26 |
| James Tobin | 26 |
| Jean-Pierre Kinet | 26 |
| Sylvie Grégoire | 25 |
- Beurs
- Insiders
- Timothy Kelly
- Bedrijfsconnecties
